Loading…
Galmed Pharmaceuticals Ltd. is projected to rise to $0.8499 by 2027, a +52% move from its current price of $0.56. GLMD is currently trading below its 50-day average (a bearish sign). Technical indicators currently lean strong sell.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 7/12/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Jul 13 | $0.5296 | $0.5605 | $0.5932 | +0.09% |
| Jul 14 | $0.5177 | $0.561 | $0.6079 | +0.18% |
| Jul 15 | $0.5089 | $0.5615 | $0.6195 | +0.27% |
| Jul 16 | $0.5017 | $0.562 | $0.6296 | +0.36% |
| Jul 17 | $0.4954 | $0.5625 | $0.6387 | +0.45% |
| Jul 18 | $0.4899 | $0.563 | $0.647 | +0.54% |
| Jul 19 | $0.4849 | $0.5635 | $0.6549 | +0.63% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $0.4849 | $0.5635 | $0.6549 | +0.63% |
| Week 2 | $0.4585 | $0.567 | $0.7013 | +1.26% |
| Week 3 | $0.4399 | $0.5706 | $0.7402 | +1.89% |
| Week 4 | $0.4252 | $0.5742 | $0.7754 | +2.53% |
| Week 5 | $0.4129 | $0.5778 | $0.8085 | +3.18% |
| Week 6 | $0.4024 | $0.5814 | $0.84 | +3.82% |
| Week 7 | $0.3932 | $0.5851 | $0.8706 | +4.47% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
Galmed Pharmaceuticals Ltd. is a biopharmaceutical company focused on the development of therapeutics for the treatment of liver diseases and related indications. The company develops Aramchol, a first-in-class synthetic fatty acid-bile acid conjugate molecule which is in a Phase III study for oral treatment for non-alcoholic steato-hepatitis (NASH) in patients who are overweight or obese and have prediabetes or type II diabetes mellitus.
Galmed was founded in 2000 and is headquartered in Ramat Gan, Israel.
Galmed Pharmaceuticals Ltd. trades under the symbol GLMD and operates in the healthcare sector with a focus on liver disease therapeutics. The current price is $0.5641 and the market cap is $3.72M, with a market ranking of 5043.
A major floor 44.8% below — a decisive break under it would weaken the trend.
The nearest floor, 16.2% below — buyers have tended to step in here.
The nearest ceiling, 34.6% above — a clean break opens room to run.
A major ceiling 57.0% above — clearing it would confirm fresh momentum.
Key GLMD support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of GLMD market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $0.5652 | Sell | $0.5679 | Sell |
| MA 10 | $0.5745 | Sell | $0.5731 | Sell |
| MA 20 | $0.5835 | Sell | $0.5826 | Sell |
| MA 50 | $0.6016 | Sell | $0.6032 | Sell |
| MA 100 | $0.6109 | Sell | $0.6616 | Sell |
| MA 200 | $0.835 | Sell | $0.9385 | Sell |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 45.64 | Neutral |
| Stoch RSI (14) | 16.27 | Buy |
| CCI (20) | -78.84 | Neutral |
| Williams %R (14) | -95.65 | Info |
| MACD (12,26,9) | -0.00 | Sell |
| ROC (12) | -2.10 | Sell |
| Bollinger %B (20,2) | 0.25 | Neutral |
| Stochastic %K (14) | 4.35 | Buy |
| TRIX (15) | -0.30 | Sell |
| Awesome (5,34) | -0.04 | Sell |
| Ultimate (7,14,28) | 47.90 | Neutral |
| Momentum (10) | -0.01 | Sell |
| Aroon Osc (25) | -8.00 | Sell |
| Hull MA (9) | 0.56 | Sell |
| ADX (14) | 9.14 | Neutral |
| ATR (14) | 0.02 | Info |
The 30-day technical picture is BEARISH, with RSI14 at 40. The stock is trading below its SMA50 of $0.6323 and SMA200 of $0.8916, indicating potential ongoing softness. Support is noted at $0.469 and resistance at $0.754, suggesting limited near-term downside but an upside cap near the resistance level.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $0.469 | $0.56 | $0.8391 | 0% | Neutral | |
| $0.6167 | $0.8499 | $1.27 | +52% | Bullish | |
| $0.5096 | $0.7464 | $1.19 | +33% | Bullish | |
| $0.5338 | $0.8235 | $1.37 | +47% | Bullish | |
| $0.4894 | $0.7915 | $1.37 | +41% | Bullish | |
| $0.3655 | $0.6179 | $1.11 | +10% | Neutral | |
| $0.496 | $0.8746 | $1.62 | +56% | Bullish | |
| $0.6168 | $1.13 | $2.16 | +102% | Bullish | |
| $0.6011 | $1.15 | $2.24 | +105% | Bullish | |
| $0.5695 | $1.13 | $2.26 | +102% | Bullish | |
| $0.7176 | $1.59 | $3.50 | +185% | Bullish | |
| $1.17 | $2.59 | $5.96 | +363% | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| July 2026 | $0.469 | $0.56 | $0.6577 | +0.00% |
| August 2026 | $0.4527 | $0.5483 | $0.6916 | -2.08% |
| September 2026 | $0.4946 | $0.6075 | $0.7824 | +10.80% |
| October 2026 | $0.4964 | $0.6172 | $0.8089 | +1.60% |
| November 2026 | $0.4729 | $0.5943 | $0.7901 | -3.72% |
| December 2026 | $0.4909 | $0.6229 | $0.8391 | +4.82% |
Click any year to see its month-by-month GLMD forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
Galmed Pharmaceuticals Ltd.'s 2026 outlook centres on $0.56, within a $0.469 to $0.8391 range. That marks a 0% change versus current levels. A consolidation phase looks the most probable path here.
By 2027, GLMD could reach as high as $1.27, with a base case around $0.8499 and support toward $0.6167 — roughly +52% from $0.56. Momentum favours further upside here.
Expect GLMD to range from $0.5096 to $1.19 through 2028. The $0.7464 average target implies a +33% move from current prices. That is -12% versus the projected 2027 average. Buyers look set to stay in control over this stretch.
The GLMD price prediction for 2029 points to an average of $0.8235 (low $0.5338, high $1.37) — a potential gain of +47% on today's $0.56. Momentum favours further upside here.
In 2030, GLMD is projected to trade between $0.4894 and $1.37, averaging $0.7915 — a potential gain of +41% from today's $0.56. That is -4% versus the projected 2029 average. Buyers look set to stay in control over this stretch.
Galmed Pharmaceuticals Ltd.'s 2031 outlook centres on $0.6179, within a $0.3655 to $1.11 range. That is -22% versus the projected 2030 average. That marks a +10% change versus current levels. Price action looks broadly range-bound.
By 2032, GLMD could reach as high as $1.62, with a base case around $0.8746 and support toward $0.496 — roughly +56% from $0.56. Buyers look set to stay in control over this stretch.
Expect GLMD to range from $0.6168 to $2.16 through 2033. The $1.13 average target implies a +102% move from current prices. That is up +30% on the projected 2032 average. Momentum favours further upside here.
The GLMD price prediction for 2034 points to an average of $1.15 (low $0.6011, high $2.24) — a potential gain of +105% on today's $0.56. Buyers look set to stay in control over this stretch.
In 2035, GLMD is projected to trade between $0.5695 and $2.26, averaging $1.13 — a potential gain of +102% from today's $0.56. That is -2% versus the projected 2034 average. Momentum favours further upside here.
Galmed Pharmaceuticals Ltd.'s 2040 outlook centres on $1.59, within a $0.7176 to $3.50 range. That is up +41% on the projected 2035 average. That marks a +185% change versus current levels. Buyers look set to stay in control over this stretch.
By 2050, GLMD could reach as high as $5.96, with a base case around $2.59 and support toward $1.17 — roughly +363% from $0.56. Momentum favours further upside here.
Investing $1,000 in GLMD today (≈ 1,785.714286 GLMD) could be worth
$4,627.61
+$3,627.61 (+363%) by 2050 · US Dollar
Based on the average projected GLMD price of $2.59 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in GLMDwould be worth at today's price.
$1,000 invested in GLMD on Jul 10, 2025 (≈ 492.610844 GLMD) would be worth
$275.86
-$724.14 (-72.4%) today · 0.28× · US Dollar
Based on a GLMD entry price of $2.03 vs. today's $0.56.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $0.57 | $982.46 | -1.8% |
| 1 month ago | $0.525 | $1,066.67 | +6.7% |
| 3 months ago | $0.741 | $755.74 | -24.4% |
| 6 months ago | $0.836 | $669.86 | -33.0% |
| 1 year ago | $2.03 | $275.86 | -72.4% |
| All time (5.0y) ago | $498.6 | $1.12 | -99.9% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our GLMD forecast.
Our base-case forecast reaches $1.10 around 2033.
Implied market cap at $1.10: $7.26M
The multi-year forecast depicts a bullish trajectory beyond the near term. For 2026, the average price is $0.5641 with a 0 ROI and a neutral sentiment. In the 2030s, the forecast shows an average of $0.7577 with a 34.3 ROI and a bullish sentiment, followed by higher long-run levels: 2040 average $1.55 with a 175.1 ROI and bullish sentiment, and 2050 average $2.48 with a 339.9 ROI and bullish sentiment.
The outlook is not uniform: 2031 shows a neutral sentiment with a 5.2 ROI, underscoring that some years carry modest upside while others reflect stronger gains in the long term.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $0.7577 with a 34.3 ROI and a BULLISH sentiment. These are estimates, not guarantees.
Yes—the 2035 forecast lists a max of $2.26, with an average of $1.13 and a 100.2 ROI, and a BULLISH sentiment.
Current price is $0.5641 and market cap is $3.72M.
RSI14 is 40 and the sentiment is BEARISH. The stock trades below SMA50 ($0.6323) and SMA200 ($0.8916), with support at $0.469 and resistance at $0.754. The 30-day range runs from $0.3649 to $0.8721.
In 2040 the average price is $1.55 with a 175.1 ROI and BULLISH sentiment, and in 2050 the average price is $2.48 with a 339.9 ROI and BULLISH sentiment. The overall path shows rising averages and strong longer-term upside, tempered by some years with neutral sentiment (e.g., 2026 and 2031).
Galmed Pharmaceuticals Ltd. Community Discussion
0Share your Galmed Pharmaceuticals Ltd. price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.